주요우울증 환자에게 있어서 약물에 대한 초기 반응과 2주 후의 증상 개선과의 관계 = Initial Response to Medication Predicts Early Improvement after 2 Weeks in Patients with Major Depressive Disorder

다국어 초록 (Multilingual Abstract)

Background and Objectives : A number of large-scale study and meta-analyses suggested that some current antidepressant treatments can exert some beneficial effect within the first week. With earlier prediction, we can avoid time wasting with unpromising medications and optimize medication for MDD patients. We investigated whether initial clinical change (ICC) and initial subjective response (ISR) can predict early improvement of antidepressant pharmacotherapy. Materials and Method : The symptoms of depression were assessed on the Hamilton Rating Scale for Depression. ISR was checked by a Korean translation form of the Modified Van Putten and May scale. CGI-I was used to assess ICC. Ratings were made on day 0, 1, 2, 4, 7 and 14. We employed Pearson’s correlation analysis and multivariate logistic regression analyses. Sensitivity, specificity and receiver operating characteristic (ROC) curves were calculated. Results : Among 33 MDD patients, 72.7% of patients achieved early improvement on HAMD-17. Significant correlation between initial response (ICC or ISR on 4 and 7 day) and early improvement were found. CGI-I score of ≤3 and change in Modified Van Putten and May scale score of ≥9 on day 7 predicted later early improvement. Conclusion : The findings show that ICC and ISR might be significant predictors of early improvement in MDD pharmacotherapy.

참고문헌 (Reference)

1 Katz MM, "‘Delay’ hypothesis of onset of antidepressant action" 188 : 586-, 2006

2 McIntyre RS, "When should you move beyond first-line therapy for depression?" 71 (71): 16-20, 2010

3 Schulberg HC, "Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines" 55 : 1121-1127, 1998

4 Farabaugh A, "The relationship between early changes in the HAMD-17anxiety/somatization factor items and treatment outcome among depressed outpatients" 20 : 87-91, 2005

5 Wade A, "The onset of effect for escitalopram and its relevance for the clinical management of depression" 22 : 2101-2110, 2006

6 Baskaran A, "The neurobiology of the EEG biomarker as a predictor of treatment response in depression" 63 : 507-513, 2012

7 Del-Ben CM, "The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study" 30 : 1724-1734, 2005

8 Van Putten T, "Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point" 35 : 477-480, 1978

9 Taylor MJ, "Rapid onset of true antidepressant action" 9 : 475-479, 2007

10 American Psychiatric Association, "Practice guideline for the treatment of patients with major depressive disorder"

11 Moller HJ, "Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale" 251 (251): II13-II20, 2001

12 Priebe S, "Initial response to active drug and placebo predicts outcome of antidepressant treatment" 12 : 28-33, 1997

13 Kim JM, "Improvement within 2 weeks and later treatment outcomes in patients with depressive disorders: the CRESCEND study" 129 : 183-190, 2011

14 Harmer CJ, "Effect of acute antidepressant administration on negative affective bias in depressed patients" 166 : 1178-1184, 2009

15 Taylor MJ, "Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis" 63 : 1217-1223, 2006

16 Nierenberg AA, "Early nonresponse to fluoxetine as a predictor of poor 8-week outcome" 152 : 1500-1503, 1995

17 Szegedi A, "Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression" 64 : 413-420, 2003

18 Szegedi A, "Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients" 70 : 344-353, 2009

19 Guy W, "ECDEU assessment maual for psychopharmacology"

20 Leuchter AF, "Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study" 169 : 124-131, 2009

21 Ruhe HG, "Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores" 46 : 417-427, 2005

22 Jick H, "Antidepressants and the risk of suicidal behaviors" 292 : 338-343, 2004

23 Nakajima S, "Accelerating response to antidepressant treatment in depression: a review and clinical suggestions" 34 : 259-264, 2010

24 Hamilton M, "A rating scale for depression" 23 : 56-62, 1960